Tyra Biosciences (TYRA) news
Recent news
Tyra Biosciences amends sales agreement on Aug 4, 2026 to increase maximum offering price for common stock - SEC filing
AInvest Wire · Aug 4, 2026Tyra Biosciences Inc: JonesTrading initiates coverage with buy rating; target price $56
JonesTrading has initiated coverage of Tyra Biosciences Inc (NASDAQ:TYRA) with a "Buy" rating and a target price of $56 per share, reflecting optimism about the company’s pipeline and clinical progress. This move aligns with broader analyst sentiment, as 9 analysts have assigned a "Strong Buy"…
AInvest Wire · Jun 17, 2026Bluenord ASA - reiterates its previously communicated production guidance for Q2 2026
BlueNord ASA has reiterated its previously communicated production guidance for the second quarter of 2026, maintaining its quarterly range of 42.0–45.0 mboepd. This follows strong operational performance in Q1 2026, during which the company achieved net hydrocarbon production of 43.1 mboepd ,…
AInvest Wire · Jun 5, 2026Bluenord ASA - in May 2026, preliminary production was 37.1 MBOEPD net to company
BlueNord ASA reported preliminary production for May 2026 at 37.1 mboepd net to the company, a decrease compared to the 43.6 mboepd recorded in April 2026 . The decline in production was primarily attributed to operational challenges at the Tyra hub and base assets. At Tyra, production was impacted…
AInvest Wire · Jun 5, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.